Stocks Overview

LAST PRICE
27.9900
TODAY'S CHANGE (%)
Trending Down-0.0200 (-0.0714%)

Bid / Lots
27.5000/ 2
Ask / Lots
28.5200/ 1
Open / Previous Close
27.9800 / 28.0100
Day Range
Low 27.7700
High 28.0800
52 Week Range
Low 26.3200
High 42.7200
Volume
400,985
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 28.01
Time	Volume	GMAB
09:32 ET	4080	27.95
09:34 ET	200	27.93
09:36 ET	1118	27.91
09:38 ET	1031	27.95
09:39 ET	2045	27.96
09:41 ET	2240	27.94
09:43 ET	1300	27.92
09:45 ET	2277	27.93
09:48 ET	1036	27.96
09:50 ET	100	27.98
09:52 ET	1452	28
09:54 ET	3467	27.99
09:56 ET	700	28.01
09:57 ET	500	28.01
09:59 ET	1600	27.98
10:01 ET	200	28
10:03 ET	612	27.9787
10:06 ET	300	27.97
10:08 ET	100	27.92
10:12 ET	200	27.95
10:14 ET	800	27.93
10:15 ET	2991	27.92
10:17 ET	2186	27.93
10:19 ET	500	27.92
10:21 ET	4116	27.91
10:24 ET	2442	27.9
10:26 ET	850	27.97
10:30 ET	2991	27.95
10:32 ET	1000	27.98
10:33 ET	200	27.96
10:35 ET	300	27.99
10:37 ET	346	28.03
10:39 ET	900	28.03
10:42 ET	2682	28.04
10:44 ET	400	28.05
10:46 ET	2007	28.045
10:48 ET	1400	28.06
10:50 ET	614	28.03
10:51 ET	534	28.02
10:53 ET	1043	27.953
10:55 ET	1285	27.96
10:57 ET	400	27.94
11:00 ET	6965	27.9
11:02 ET	208	27.88
11:04 ET	2186	27.89
11:06 ET	300	27.89
11:09 ET	100	27.85
11:11 ET	503	27.83
11:13 ET	600	27.805
11:15 ET	3763	27.8
11:18 ET	2548	27.835
11:20 ET	2302	27.78
11:22 ET	832	27.79
11:24 ET	100	27.77
11:26 ET	1293	27.78
11:27 ET	200	27.795
11:29 ET	3002	27.82
11:31 ET	1593	27.865
11:33 ET	784	27.845
11:36 ET	100	27.87
11:38 ET	400	27.89
11:40 ET	200	27.87
11:42 ET	14865	27.91
11:44 ET	2288	27.915
11:45 ET	1199	27.91
11:47 ET	532	27.92
11:49 ET	1399	27.88
11:51 ET	2305	27.85
11:54 ET	200	27.87
11:56 ET	564	27.88
11:58 ET	229	27.885
12:00 ET	100	27.9
12:02 ET	200	27.9
12:03 ET	1701	27.87
12:05 ET	100	27.875
12:07 ET	100	27.875
12:09 ET	4824	27.8791
12:12 ET	800	27.91
12:14 ET	4899	27.895
12:16 ET	900	27.915
12:23 ET	100	27.905
12:30 ET	1495	27.925
12:32 ET	400	27.92
12:34 ET	600	27.95
12:36 ET	530	27.94
12:39 ET	2627	27.95
12:41 ET	3813	27.91
12:43 ET	2035	27.89
12:45 ET	1200	27.93
12:48 ET	100	27.92
12:50 ET	212	27.94
12:52 ET	200	27.95
12:54 ET	300	27.95
12:56 ET	100	27.945
12:59 ET	200	27.92
01:01 ET	200	27.915
01:03 ET	222	27.885
01:08 ET	300	27.9
01:10 ET	720	27.8967
01:12 ET	1150	27.91
01:15 ET	2327	27.91
01:17 ET	400	27.95
01:19 ET	300	27.95
01:21 ET	100	27.95
01:24 ET	760	27.9425
01:26 ET	300	27.94
01:28 ET	300	27.93
01:30 ET	300	27.94
01:32 ET	100	27.95
01:33 ET	700	27.92
01:35 ET	200	27.93
01:42 ET	400	27.88
01:44 ET	200	27.86
01:46 ET	1050	27.88
01:48 ET	237	27.88
01:50 ET	128	27.845
01:51 ET	400	27.86
01:53 ET	200	27.87
01:55 ET	200	27.87
01:57 ET	300	27.86
02:02 ET	200	27.87
02:04 ET	423	27.86
02:06 ET	512	27.85
02:08 ET	500	27.85
02:09 ET	200	27.85
02:11 ET	334	27.83
02:13 ET	1783	27.8234
02:15 ET	2342	27.86
02:18 ET	300	27.86
02:20 ET	454	27.87
02:22 ET	353	27.87
02:24 ET	1134	27.845
02:26 ET	653	27.85
02:27 ET	100	27.87
02:29 ET	740	27.8686
02:31 ET	1460	27.87
02:33 ET	1133	27.835
02:36 ET	724	27.85
02:38 ET	400	27.85
02:42 ET	398	27.85
02:44 ET	200	27.88
02:45 ET	519	27.86
02:47 ET	683	27.88
02:51 ET	150	27.87
02:54 ET	100	27.86
02:56 ET	146	27.86
02:58 ET	936	27.8514
03:02 ET	100	27.85
03:03 ET	918	27.855
03:05 ET	960	27.8657
03:07 ET	900	27.86
03:09 ET	443	27.8713
03:12 ET	100	27.87
03:14 ET	612	27.87
03:18 ET	690	27.88
03:20 ET	400	27.88
03:21 ET	200	27.89
03:23 ET	310	27.89
03:25 ET	600	27.88
03:27 ET	500	27.88
03:30 ET	1000	27.915
03:32 ET	2054	27.91
03:34 ET	2800	27.94
03:36 ET	600	27.96
03:38 ET	2900	27.95
03:39 ET	1660	27.96
03:41 ET	2800	27.97
03:43 ET	5983	27.982
03:45 ET	7652	27.99
03:48 ET	5633	27.99
03:50 ET	6562	27.98
03:52 ET	9244	27.98
03:54 ET	8927	27.97
03:56 ET	11835	27.97
03:57 ET	16446	27.98
03:59 ET	18143	27.99

Data delayed at least 15 minutes.

May 23, 2024
- Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, from 5:00PM ET on Thursday May 23, 2024 by Dow Jones
  5:00PM ET on Thursday May 23, 2024 by Dow Jones
- DJ Genmab A/S Stock Falls Thursday, Underperforms Market, from 12:01PM ET on Thursday May 23, 2024 by Dow Jones
  12:01PM ET on Thursday May 23, 2024 by Dow Jones
May 22, 2024
- DJ Genmab A/S Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday May 22, 2024 by Dow Jones
  12:01PM ET on Wednesday May 22, 2024 by Dow Jones
May 21, 2024
- DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 11:31AM ET on Tuesday May 21, 2024 by Dow Jones
  11:31AM ET on Tuesday May 21, 2024 by Dow Jones
- *DJ Genmab Completes Acquisition Of ProfoundBio >GMAB, from 11:10AM ET on Tuesday May 21, 2024 by Dow Jones
  11:10AM ET on Tuesday May 21, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesGMAB Genmab A/S	18.6B	23.2x	+22.71%
United StatesDNLI Denali Therapeutics Inc	2.7B	-18.7x	---
United StatesMRVI Maravai LifeSciences Holdings Inc	2.7B	-9.0x	---
United StatesFOLD Amicus Therapeutics Inc	2.8B	-19.0x	---
United StatesMOR MorphoSys AG	2.8B	-5.4x	---
United StatesGLPG Galapagos NV	1.8B	53.3x	---
As of 2024-05-29

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Contact Information

Headquarters: Kalvebod Brygge 43KOEBENHAVN V, Denmark 1560
Phone: ---
Fax: ---

Executives

Independent Chairman of the Board: Deirdre Connelly
President, Chief Executive Officer: Jan Van De Winkel
Independent Deputy Chairman of the Board: Pernille Erenbjerg
Chief Financial Officer, Executive Vice President: Anthony Pagano
Chief Operating Officer, Executive Vice President: Anthony Mancini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$18.6B
Revenue (TTM)	$2.6B
Shares Outstanding	661.3M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.98
EPS	$1.20
Book Value	$7.04
P/E Ratio	23.2x
Price/Sales (TTM)	7.2
Price/Cash Flow (TTM)	---
Operating Margin	32.00%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Genmab A/S
NASDAQ:GMABUnited States

Search Criteria

Charts

Recent News

May 23, 2024

Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, from 5:00PM ET on Thursday May 23, 2024 by Dow Jones

DJ Genmab A/S Stock Falls Thursday, Underperforms Market, from 12:01PM ET on Thursday May 23, 2024 by Dow Jones

May 22, 2024

DJ Genmab A/S Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday May 22, 2024 by Dow Jones

May 21, 2024

DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 11:31AM ET on Tuesday May 21, 2024 by Dow Jones

*DJ Genmab Completes Acquisition Of ProfoundBio >GMAB, from 11:10AM ET on Tuesday May 21, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar